Mitochondrial dysfunction and the role of the non-specialist laboratory

Annals of Clinical Biochemistry

Volumn 39, Issue 5, 2002, Pages 456-463

  Hancock, Maggie R ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABACOVIR; AFEDOVIR; CARBOXYLIC ACID; CREATINE KINASE; DIDANOSINE; LACTIC ACID; LAMIVUDINE; MITOCHONDRIAL DNA; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; UNCLASSIFIED DRUG; ZALCITABINE; ZIDOVUDINE;

ASCITES; BONE MARROW DEPRESSION; BRAIN DISEASE; CEREBROSPINAL FLUID LEVEL; CLINICAL FEATURE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENDOCRINE DISEASE; ENDOCRINE FUNCTION TEST; GENE MUTATION; HEPATOMEGALY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY FUNCTION TEST; KIDNEY TUBULE ACIDOSIS; LABORATORY TEST; LACTATE BLOOD LEVEL; LACTIC ACIDOSIS; LIPODYSTROPHY; LIVER FUNCTION TEST; MUSCLE DISEASE; MYOGLOBINURIA; NEUROLOGIC DISEASE; OXIDATIVE PHOSPHORYLATION; PANCREATITIS; PRIORITY JOURNAL; REVIEW; STEATOSIS;

CELL RESPIRATION; DNA, MITOCHONDRIAL; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; MITOCHONDRIAL DISEASES; MITOCHONDRIAL ENCEPHALOMYOPATHIES; REVERSE TRANSCRIPTASE INHIBITORS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0036729766     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1258/000456302320314467     Document Type: Review

References (42)

1. Mitochondrial disorders
2. Mitochondrial DNA and disease
3. Diagnosis and incidence of mitochondrial respiratory chain disease in adults
4. Inborn and induced defects of mitochondria
5. Adverse effects of antiretroviral therapy
6. Respiratory chain encephalomyopathies: A diagnostic classification
7. Morphological correlates of mitochondrial dysfunction in children
8. Mitochondrial DNA analysis: Polymorphisms and pathogenicity
9. Practical problems in detecting abnormal mitochondrial function and genomes
10. Respiratory chain disorders: Can we establish consensus on diagnosis?
11. Sequence and organisation of the human mitochondrial genome
12. The new genetics and mitochondrial respiratory chain disorders
13. Studies on the inhibition of mitochondrial DNA replication by 3′-azido-3′-deoxythymidine
14. Barth syndrome: Clinical observations and genetic linkage studies
15. Clinical presentation of mitochondrial disorders in childhood
16. Disorders related to mitochondrial membranes: Pathology of the respiratory chain and neurodegeneration
17. Biochemical and molecular basis for mitochondrial cardiomyopathy in neonates and children
18. Mitochondrial toxicity of antiretroviral drugs
19. Zidovudine-induced mitochondrial disorder with massive liver steatosis, myopathy, lactic acidosis and mitochondrial DNA depletion
20. Fatal portal hypertension, liver failure and mitochondrial dysfunction after HIV-1 nucleoside-induced hepatitis and lactic acidaemia
21. Disorders of glucose metabolism in patients infected with human immunodeficiency virus
22. Multiple symmetrical lipomatosis: Abnormalities in complex IV and multiple deletions in mitochondrial DNA
23. Multiple symmetrical lipomatosis: An unusual cause of childhood obesity and mental retardation
24. Mitochondrial toxicity induced by nucleoside-analogue reverse transcriptase inhibitors is a key feature in the pathogenesis of antiretroviral-therapy-related lipodystrophy
25. Neurological presentations of mitochondrial disease
26. Clinical and laboratory findings in referrals for mitochondrial DNA analysis
27. Clinical and laboratory findings in referrals for mitochondrial DNA analysis
28. The investigation of patients with lactic acidaemia. Report of a BIMDG workshop
29. Diagnostic yield of the lactate stress test in respiratory chain disorders under absolute and relative workload
30. Determination of the blood lactate:pyruvate ratio as a non-invasive test for the diagnosis of Zidovudine myopathy
31. The importance of cerebrospinal fluid lactate in the evaluation of congenital lactic acidosis
32. Measurement of lactate in cerebrospinal fluid in investigation of inherited metabolic disease
33. Compromised fatty acid oxidation in mitochondrial disorders
34. Ketoacidosis: An unusual presentation of MELAS
35. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: A cohort study
36. Acute rhabdomyolysis in patients infected by human immunodeficiency virus
37. Severe recurrent renal salt wasting in a boy with a mitochondrial oxidative phosphorylation defect
38. Mitochondrial disease represents a risk factor for valproate-induced liver failure
39. Mitochondrial respiratory chain disorders I: Mitochondrial DNA defects
40. Effect of coenzyme Q10 in patients with myopathy, encephalopathy, lactic acidosis
41. Biochemical monitoring of the treatment in paediatric patients with mitochondrial disease
42. Effects of aerobic training on lactate and catecholinergic exercise responses in mitochondrial myopathies